London, UK (May 27, 2010) – When we think of ultrasound, it's usually imaging the inside of the body that springs to mind. However, while ultrasound imaging typically requires frequencies that are 50 to 2500 times higher than those human ear can detect, recent increasing evidence indicates that ultrasound at lower frequency can also be used to help certain body tissues to heal and regenerate. Now research that appears in Open Access Journal of Tissue Engineering published by SAGE-Hindawi suggests that ultrasound could also help tissue grafts to survive and thrive following surgery.
Ultrasound can improve cell viability, thanks to its ability to get molecules moving, and researchers have used it to increase blood flow to tissues in the process of healing and regenerating. In particular, low-intensity ultrasound (LIUS) has been used to help regenerate cartilage and bone, and in tissue engineering to stimulate cells.
Surgeons use a patient's own fatty tissue (adipose tissue) in procedures including facial plastic surgery, treating burn victims, breast reconstruction and surgery on the vocal cords. But how well these tissue grafts survive can vary, and the time period after the surgery before a blood supply is re-established is particularly critical. If the graft doesn't get sufficient oxygen and glucose, and clear away waste, the grafted tissue will wither and die.
An international research team, including researchers from MIT, the Center for Laryngeal Surgery and Voice Rehabilitation at Massachusetts General Hospital, Boston and Ben Gurion University in Beer-Sheva, Israel, set out to test whether ultrasound could improve the viability of grafted tissue during the post-op period.
The researchers used adipose cells cultured from tissue left over from tummy-tuck operations as well as mouse muscle cells (C2C12 cells) for their experiments. Over a six-day period, the test cells were treated with LIUS at 30mW/cm2 for short bursts of three or ten minutes. They assayed for the number of cells, metabolism (by observing how much glucose they consumed and how much lactate they produced), viability and for signs of damage to the cells.
The C2C12 muscle cells stimulated with LIUS showed greater cell numbers and better viability than controls. Also for the first time the researchers obtained preliminary evidence that LIUS can influence the viability of the cultured adipose cells (known as organoids) in an in vitro organ culture model. Adipose tissue treated with LIUS showed significantly increased metabolic activity, and had fewer markers for tissue damage than tissue not treated with LIUS.
If the technique was used on a patient, the way that ultrasound might enhance molecular motion would probably depend on local variations in tissue density. "Depending on the location of the probe, one can expect variable effects of LIUS," says senior author Steven Zeitels, MD, Director of the Center for Laryngeal Surgery and Voice Rehabilitation.
It's also not clear whether the increased metabolic activity and proliferation of the cells seen in this experiment was simply due to LIUS's mechanical and thermal effect in stimulating molecules to move around more. "In the context of using LIUS to enhance autograft survival, the possibility that the LIUS can directly activate signalling pathways in implanted cells needs to be taken into account. It may eventually be possible to manipulate cellular responses by fine-tuning this technique." says lead author Hyoungshin Park, PhD, from MIT.
It remains to be seen whether these laboratory results will hold up in in vivo studies, but these preliminary results suggest important avenues to pursue in efforts to improve graft survival.
Indirect low-intensity ultrasonic stimulation for tissue engineering by Hyoungshin Park, Michael Yip, Beata Chertok, Joseph Kost, James B. Kobler, Robert Langer, and Steven M. Zeitels is published in the Journal of Tissue Engineering. The Journal is Open Access and the paper is free to read online now from http://www.sage-hindawi.com/journals/jte/2010/973530.html.
Lead author contact: Steven M. Zeitels, MD
Phone 617-726-1444, Fax 617-724-9949,
SAGE-Hindawi Access to Research is a partnership between SAGE Publications and Hindawi Publishing Corporation to jointly publish a collection of open access journals on a variety of subjects in science, technology, and medicine. http://www.sage-hindawi.com.
SAGE is a leading international publisher of journals, books, and electronic media for academic, educational, and professional markets. Since 1965, SAGE has helped inform and educate a global community of scholars, practitioners, researchers, and students spanning a wide range of subject areas including business, humanities, social sciences, and science, technology and medicine. An independent company, SAGE has principal offices in Los Angeles, London, New Delhi, Singapore and Washington DC. www.sagepublications.com
Hindawi Publishing Corporation is a rapidly growing open access publisher, with offices in Cairo, Egypt. Hindawi currently publishes more than 100 fully Open Access journals covering a wide range of subjects in Science, Technology, and Medicine. The company's web site is located at http://www.hindawi.com.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.